Sign inGet started

JBIO

Jade Biosciences, Inc.CIK 1798749 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
13

AI insights for JBIO PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for JBIO
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Eisner MarkDirector1$0$02026-06-25
Kiselak TomasDirector, 10% Owner1$0$02026-06-09
CAIN CHRISTOPHER W.Director2$0$02026-06-09
Klein Lawrence OttoDirector2$0$02026-06-09
Lavelle ErinDirector2$0$02026-06-09
DOBMEIER ERICDirector2$0$02026-06-09
Balta ElizabethSee Remarks2$0$02026-02-12
Frohlich TomChief Executive Officer3$44.4K$02026-02-12
King Andrew JamesSee Remarks2$0$02026-02-12
Dahms Bradford D.Chief Financial Officer3$0$02026-02-12
Fairmount Healthcare Fund II L.P.Director, 10% Owner2$0$02025-10-06
Harwin Peter EvanDirector, 10% Owner1$0$02025-04-29
Kolchinsky Peter10% Owner1$0$02025-04-28

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Eisner MarkDirector A Award deriv2026-06-252026-06-2647,675— $047,675SEC↗
Kiselak TomasDirector, 10% Owner A Award deriv2026-06-092026-06-1134,843— $034,843SEC↗
Lavelle ErinDirector A Award deriv2026-06-092026-06-1134,843— $034,843SEC↗
Klein Lawrence OttoDirector A Award deriv2026-06-092026-06-1134,843— $034,843SEC↗
DOBMEIER ERICDirector A Award deriv2026-06-092026-06-1134,843— $034,843SEC↗
CAIN CHRISTOPHER W.Director A Award deriv2026-06-092026-06-1134,843— $034,843SEC↗
King Andrew JamesSee Remarks A Award deriv2026-02-122026-02-13247,500— $0247,500SEC↗
Frohlich TomChief Executive Officer A Award deriv2026-02-122026-02-13472,500— $0472,500SEC↗
Balta ElizabethSee Remarks A Award deriv2026-02-122026-02-13168,750— $0168,750SEC↗
Dahms Bradford D.Chief Financial Officer A Award deriv2026-02-122026-02-13226,875— $0226,875SEC↗
King Andrew JamesSee Remarks A Award2026-02-122026-02-1341,250— $0386,113SEC↗
Frohlich TomChief Executive Officer A Award2026-02-122026-02-1378,750— $086,331SEC↗
Balta ElizabethSee Remarks A Award2026-02-122026-02-1328,125— $028,125SEC↗
Dahms Bradford D.Chief Financial Officer A Award2026-02-122026-02-1337,813— $037,813SEC↗
Fairmount Healthcare Fund II LDirector, 10% Owner A Award deriv2025-10-062025-10-08855,047$9.14 $7.82M855,047SEC↗
Fairmount Healthcare Fund II LDirector, 10% Owner A Award2025-10-062025-10-081,333,126$9.14 $12.18M1,897,677SEC↗
Dahms Bradford D.Chief Financial Officer A Award deriv2025-07-142025-07-14526,000— $0526,000SEC↗
Frohlich TomChief Executive Officer P Buy2025-05-162025-05-196,000$7.40 $44.4K6,000SEC↗
DOBMEIER ERICDirector A Award deriv2025-04-292025-05-0123,017— $023,017SEC↗
CAIN CHRISTOPHER W.Director A Award deriv2025-04-292025-05-0123,017— $023,017SEC↗
Klein Lawrence OttoDirector A Award deriv2025-04-292025-05-0123,017— $023,017SEC↗
Lavelle ErinDirector A Award deriv2025-04-292025-05-0123,017— $023,017SEC↗
Harwin Peter EvanDirector, 10% Owner A Award deriv2025-04-292025-05-0123,017— $023,017SEC↗
Kolchinsky Peter10% Owner J Other2025-04-282025-04-301,062,326— $01,287,858SEC↗